Skip to main content
. 2019 Aug 26;9:12366. doi: 10.1038/s41598-019-48885-9

Figure 3.

Figure 3

Methylmalonic acid (A), MCA (B) and MCA/CA (C) in daily consecutive DBS samples (n = 11) collected from a vitamin B12 responsive MMA patient before and after starting treatment with IM hydroxycobalamin (1.0 mg/day). Methylmalonic acid (D), MCA (E) and MCA/CA (F) in daily consecutive DBS samples (n = 34) collected from a vitamin B12 non-responsive MMA patient before and after starting treatment with IM hydroxycobalamin (1.0 mg/day).